Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.
This report elaborates on the current development of the Opioid-Induced Constipation industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Bayer
AstraZeneca
GSK
Daiichi Sankyo
Nektar Therapeutics
Mallinckrodt
Progenics Pharmaceuticals
Sanofi
Salix (Bausch Health)
Takeda Pharmaceuticals
Prestige
Shionogi
Purdue Pharm
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Methylnaltrexone Bromide
Lubiprostone
Naloxegol
Others
Application:
Hospital
Pharmacy
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Opioid-Induced Constipation Industry Overview
-
1.1.1 Opioid-Induced Constipation Market Scope and Market Segments
-
1.1.2 Opioid-Induced Constipation Industry Characteristics
-
1.1.3 Global and China Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Opioid-Induced Constipation Production Value and Growth Rate (2017-2028)
-
1.2 Global Opioid-Induced Constipation Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Methylnaltrexone Bromide
-
1.2.2 Lubiprostone
-
1.2.3 Naloxegol
-
1.2.4 Others
-
1.3 Global Opioid-Induced Constipation Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Pharmacy
-
1.4 Market Analysis by Region
-
1.4.1 North America Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Opioid-Induced Constipation Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Opioid-Induced Constipation Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Opioid-Induced Constipation Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Opioid-Induced Constipation Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Opioid-Induced Constipation Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Opioid-Induced Constipation Industry Porter's Five Forces Model Analysis
-
2.2.3 Opioid-Induced Constipation Industry PEST Analysis
-
2.3 Opioid-Induced Constipation Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Opioid-Induced Constipation Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Opioid-Induced Constipation Industry
Chapter 3 Global and China Opioid-Induced Constipation Market, by Manufacturer
-
3.1 Global and China Opioid-Induced Constipation Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Opioid-Induced Constipation Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Opioid-Induced Constipation Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Opioid-Induced Constipation Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Opioid-Induced Constipation Market Top 3 Players
Chapter 4 Global and China Opioid-Induced Constipation Market, by Type (2017-2028)
-
4.1 Opioid-Induced Constipation Market Trend, by Type
-
4.2 Global Opioid-Induced Constipation Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Opioid-Induced Constipation Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Opioid-Induced Constipation Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Opioid-Induced Constipation Price Trend, by Type (2017-2028)
-
4.3 China Opioid-Induced Constipation Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Opioid-Induced Constipation Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Opioid-Induced Constipation Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Opioid-Induced Constipation Price Trend, by Type (2017-2028)
Chapter 5 Global and China Opioid-Induced Constipation Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Opioid-Induced Constipation Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Opioid-Induced Constipation Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Opioid-Induced Constipation Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Opioid-Induced Constipation Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Opioid-Induced Constipation Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Opioid-Induced Constipation Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Opioid-Induced Constipation Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Opioid-Induced Constipation Market Analysis
-
7.1 North America Opioid-Induced Constipation Market, by Type
-
7.2 North America Opioid-Induced Constipation Market, by Application
-
7.3 North America Opioid-Induced Constipation Market Analysis and Forecast, by Country
-
7.3.1 United States Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Opioid-Induced Constipation Market Analysis
-
8.1 Europe Opioid-Induced Constipation Market, by Type
-
8.2 Europe Opioid-Induced Constipation Market, by Application
-
8.3 Europe Opioid-Induced Constipation Market Analysis and Forecast, by Country
-
8.3.1 Germany Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Opioid-Induced Constipation Market Analysis
-
9.1 APAC Opioid-Induced Constipation Market, by Type
-
9.2 APAC Opioid-Induced Constipation Market, by Application
-
9.3 APAC Opioid-Induced Constipation Market Analysis and Forecast, by Country
-
9.3.1 China Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Opioid-Induced Constipation Market Analysis
-
10.1 Latin America, Middle East and Africa Opioid-Induced Constipation Market, by Type
-
10.2 Latin America, Middle East and Africa Opioid-Induced Constipation Market, by Application
-
10.3 Latin America, Middle East and Africa Opioid-Induced Constipation Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Opioid-Induced Constipation Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Opioid-Induced Constipation Company Profiles
-
11.1 Bayer
-
11.1.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Bayer Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.1.3 Bayer Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 AstraZeneca
-
11.2.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 AstraZeneca Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.2.3 AstraZeneca Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 GSK
-
11.3.1 GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 GSK Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.3.3 GSK Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Daiichi Sankyo
-
11.4.1 Daiichi Sankyo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Daiichi Sankyo Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.4.3 Daiichi Sankyo Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Nektar Therapeutics
-
11.5.1 Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Nektar Therapeutics Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.5.3 Nektar Therapeutics Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Mallinckrodt
-
11.6.1 Mallinckrodt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Mallinckrodt Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.6.3 Mallinckrodt Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Progenics Pharmaceuticals
-
11.7.1 Progenics Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Sanofi
-
11.8.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Sanofi Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.8.3 Sanofi Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Salix (Bausch Health)
-
11.9.1 Salix (Bausch Health) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Salix (Bausch Health) Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.9.3 Salix (Bausch Health) Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Takeda Pharmaceuticals
-
11.10.1 Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.10.3 Takeda Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Prestige
-
11.11.1 Prestige Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Prestige Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.11.3 Prestige Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Shionogi
-
11.12.1 Shionogi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Shionogi Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.12.3 Shionogi Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Purdue Pharm
-
11.13.1 Purdue Pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Purdue Pharm Opioid-Induced Constipation Product Profiles, Application and Specification
-
11.13.3 Purdue Pharm Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Opioid-Induced Constipation Industry Investment Prospect and Risk Assessment
-
12.1 Opioid-Induced Constipation Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Opioid-Induced Constipation Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Global Opioid-Induced Constipation Production Value and Growth Rate (2017-2028)
-
Figure China Opioid-Induced Constipation Production Value and Growth Rate (2017-2028)
-
Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Methylnaltrexone Bromide (2017-2028)
-
Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Lubiprostone (2017-2028)
-
Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Naloxegol (2017-2028)
-
Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Others (2017-2028)
-
Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Opioid-Induced Constipation Market Size and Growth Rate of Pharmacy (2017-2028)
-
Figure North America Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Opioid-Induced Constipation Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Opioid-Induced Constipation Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Opioid-Induced Constipation Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Opioid-Induced Constipation Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Opioid-Induced Constipation Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Opioid-Induced Constipation Market Share, by Manufacturer in 2021
-
Figure Global and China Opioid-Induced Constipation Market Share, by Manufacturer in 2022
-
Table Global Opioid-Induced Constipation Sales Volume, by Type (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Figure Global Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Value, by Type (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Value Share, by Type (2017-2028)
-
Figure Global Opioid-Induced Constipation Price Trend, by Type (2017-2028)
-
Table China Opioid-Induced Constipation Sales Volume, by Type (2017-2028)
-
Table China Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Table China Opioid-Induced Constipation Sales Value, by Type (2017-2028)
-
Table China Opioid-Induced Constipation Sales Value Share, by Type (2017-2028)
-
Figure China Opioid-Induced Constipation Price Trend, by Type (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Volume, by Application (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure Global Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Value, by Application (2017-2028)
-
Table Global Opioid-Induced Constipation Sales Value Share, by Application (2017-2028)
-
Figure Global Opioid-Induced Constipation Sales Value Share, by Application (2017-2028)
-
Table China Opioid-Induced Constipation Sales Volume, by Application (2017-2028)
-
Table China Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Table China Opioid-Induced Constipation Sales Value, by Application (2017-2028)
-
Table China Opioid-Induced Constipation Sales Value Share, by Application (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Value Share, by Application (2017-2028)
-
Figure China Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
Figure North America Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Opioid-Induced Constipation Production, Import, Consumption and Export (2017-2022)
-
Table North America Opioid-Induced Constipation Sales Volume, by Type (2017-2028)
-
Table North America Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Figure North America Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Table North America Opioid-Induced Constipation Sales Volume, by Application (2017-2028)
-
Table North America Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure North America Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure United States Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure United States Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Canada Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Table Europe Opioid-Induced Constipation Sales Volume, by Type (2017-2028)
-
Table Europe Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Figure Europe Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Table Europe Opioid-Induced Constipation Sales Volume, by Application (2017-2028)
-
Table Europe Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure Europe Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure Germany Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure UK Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure UK Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure France Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure France Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Italy Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Spain Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Poland Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Russia Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Table APAC Opioid-Induced Constipation Sales Volume, by Type (2017-2028)
-
Table APAC Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Figure APAC Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Table APAC Opioid-Induced Constipation Sales Volume, by Application (2017-2028)
-
Table APAC Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure APAC Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure China Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Japan Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure India Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure India Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Opioid-Induced Constipation Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Opioid-Induced Constipation Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Opioid-Induced Constipation Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Opioid-Induced Constipation Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Opioid-Induced Constipation Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Opioid-Induced Constipation Sales Value and Growth Rate (2017-2028)
-
Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Bayer Product Profiles, Application and Specification
-
Table Bayer Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GSK Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GSK Product Profiles, Application and Specification
-
Table GSK Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Daiichi Sankyo Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Daiichi Sankyo Product Profiles, Application and Specification
-
Table Daiichi Sankyo Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Nektar Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Nektar Therapeutics Product Profiles, Application and Specification
-
Table Nektar Therapeutics Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mallinckrodt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mallinckrodt Product Profiles, Application and Specification
-
Table Mallinckrodt Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Progenics Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Progenics Pharmaceuticals Product Profiles, Application and Specification
-
Table Progenics Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Salix (Bausch Health) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Salix (Bausch Health) Product Profiles, Application and Specification
-
Table Salix (Bausch Health) Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Pharmaceuticals Product Profiles, Application and Specification
-
Table Takeda Pharmaceuticals Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Prestige Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Prestige Product Profiles, Application and Specification
-
Table Prestige Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Shionogi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Shionogi Product Profiles, Application and Specification
-
Table Shionogi Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Purdue Pharm Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Purdue Pharm Product Profiles, Application and Specification
-
Table Purdue Pharm Opioid-Induced Constipation Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
